Nuevas formas de vehiculización de agentes hipotensores para el tratamiento del glaucoma
- Andres Guerrero, Vanessa
- María del Rocío Herrero Vanrell Director
- Irene Teresa Molina Martínez Director
Universidade de defensa: Universidad Complutense de Madrid
Fecha de defensa: 29 de xuño de 2011
- Julián García Feijoo Presidente/a
- Beatriz de las Heras Polo Secretario/a
- Virginia Merino Sanjuán Vogal
- Nicolas Tsapis Vogal
- Carmen Álvarez Lorenzo Vogal
Tipo: Tese
Resumo
Glaucoma is the second leading cause of blin dness in the world. It is a chronic optic neuropathy which can lead to complete loss of vision if an adequate treatment is not used in time. At the moment there is no cure for glaucoma and the available treatments are chronic and only manage to contr ol or decrease the evolution of the pathology. These types of treatments, consisting of the instillation of eye drops once or twice per day, are usually associated to short- and long-term adverse effects that compromise the patient compliance...